An antimicrobial signaling molecule called interferon lambda 4 has lower activity against the hepatitis C virus in the vast majority of humans compared with chimpanzees and African hunter-gatherer Pygmies, according to a new study.
An antimicrobial signaling molecule called interferon lambda 4 has lower activity against the hepatitis C virus in the vast majority of humans compared with chimpanzees and African hunter-gatherer Pygmies, according to a new study.